Stanley Druckenmiller’s Verona Pharma VRNA Stock Holding History

Stanley Druckenmiller’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,002,080	Closed	-$107M	–	88
2025 Q3	$107M	Hold	1,002,080	–	–	2.63%	9
2025 Q2	$94.8M	Hold	1,002,080	–	–	2.33%	15
2025 Q1	$63.6M	Buy	1,002,080 +114,500	+13%	+$6.85M	2.08%	14
2024 Q4	$41.2M	Buy	887,580 +201,535	+29%	+$7.57M	1.11%	27
2024 Q3	$19.7M	Buy	+686,045	New	+$16.9M	0.67%	32

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Stanley Druckenmiller's VRNA Position: Q4 2025 in Review

Stanley Druckenmiller sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,002,080 shares — an estimated $107M sold.

Stanley Druckenmiller first reported a position in VRNA in Q3 2024 and held it in 5 quarters. The position peaked at $107M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Stanley Druckenmiller reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Stanley Druckenmiller sold 1,002,080 Verona Pharma shares in Q4 2025, an estimated $107M.
Stanley Druckenmiller first reported a position in Verona Pharma in Q3 2024 and held it in 5 quarters.
Stanley Druckenmiller's Verona Pharma position peaked at $107M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Duquesne Family Office's 13F filing for Q4 2025, filed 17 Feb 2026.